Cooper Profit Margin 2006-2018 | COO

Current and historical gross margin, operating margin and net profit margin for Cooper (COO) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Cooper net profit margin as of October 31, 2018 is 5.52%.
Cooper Annual Profit Margins
Cooper Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $13.769B $2.533B
The Cooper Companies, Inc. is a global medical device company. Cooper is dedicated to being A Quality of Life Company with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of families with its diversified portfolio of products and services focusing on women's health, fertility and diagnostics.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $66.819B 22.19
McKesson (MCK) United States $26.004B 10.12
Align Technology (ALGN) United States $20.393B 51.93
AmerisourceBergen (ABC) United States $18.293B 13.27
Cardinal Health (CAH) United States $16.534B 11.14
Laboratory Of America Holdings (LH) United States $15.152B 13.63
DENTSPLY SIRONA (XRAY) United States $9.699B 19.37
Henry Schein (HSIC) United States $9.511B 15.64
West Pharmaceutical Services (WST) United States $7.549B 36.27
Merit Medical Systems (MMSI) United States $3.268B 38.70
Patterson (PDCO) United States $2.196B 16.76
CONMED (CNMD) United States $2.024B 33.00
STAAR Surgical (STAA) United States $1.607B 165.54
Atrion (ATRI) United States $1.473B 42.11
Antares Pharma (ATRS) United States $0.504B 0.00
Invacare (IVC) United States $0.320B 0.00
Lifevantage (LFVN) United States $0.227B 30.54
Pro-Dex (PDEX) United States $0.065B 29.51
Endologix (ELGX) United States $0.056B 0.00
Biolase (BIOL) United States $0.044B 0.00
Aceto (ACET) United States $0.034B 0.00